Metabolic features of the inflammatory syndrome of chronic pelvic pain (category IIIA of chronic non-bacterial prostatitis) in young men, depending on the somatotype

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Purpose. dentification of bioimpedance and clinical features in young men with chronic pelvic pain inflammatory syndrome (CP/CPPS NIH IIIa) depending on the somatotype.

Methods. 150 men of the first period of adulthood from 22 to 35 years old with CP/CPPS NIH IIIa were examined from 2018 to 2022 years. The average age was 31 [28; 34] year. Somatotypes were computed according to Carter and Heath. Body composition was assessed anthropometry and bioimpedance analysis.

Results. Ectomorphs had the least clinical, laboratory and instrumental manifestations of CP/CPPS NIH IIIa, the levels of total and free testosterone were the highest. The active cell mass predominated in the component composition of the body. Manifestations in mesomorphs had a moderate degree of severity. Endomorphs had the most severe manifestations of CP/CPPS NIH IIIa, the largest amount of fat mass was noted in the body composition than in men of other somatotypes, the hormonal status was characterized by the lowest levels of free and total testosterone, and the highest level of estradiol.

Discussion. Based on the literature data and our own results, it can be assumed that the identified changes in the body component composition and hormonal status of men contribute to the maintenance of chronic inflammation in the prostate, organ ischemia, impaired intracranial metabolism, recurrent course of CP/CPPS NIH IIIa, which significantly reduces the patient’s quality of life and increases the risk of prostate inflammation with age.

Conclusion. Determining the somatotype and conducting a component analysis of body composition allows patients to be divided into groups according to the severity of manifestations of CP/CPPS NIH IIIa. The revealed patterns allow us to classify male endomorphs into the group with the most severe manifestations of CP/CPPS NIH IIIa.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Yu. Vinnik

Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation

Хат алмасуға жауапты Автор.
Email: vinnik33@mail.ru
ORCID iD: 0000-0002-8135-0445

Doctor of Medical Science, Professor of Department of Urology, Andrology and Sexology Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation

Ресей, Krasnoyarsk

A. Amelchenko

Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: vinnik33@mail.ru
ORCID iD: 0000-0003-2867-4317

graduate student of Department of Urology, Andrology and Sexology Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation

Ресей, Krasnoyarsk

Әдебиет тізімі

  1. Krieger JN, Nyberg L, Jr., Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282(3):236–237. doi: 10.1001/jama.282.3.236
  2. Bozhedomov V.А., Semenov А.V., Patsanovskaya G.М. et al. Men’s reproductive function at chronic prostatitis: clinical, anamneses and microbiologic aspects. Urologiya. 2015;(1):70–78. Russian (Божедомов В.А., Семенов А.В., Пацановская Г.М. и др. Репродуктивная функция мужчин при хроническом простатите: клинико-анамнестические и микробиологические аспекты. Урология. 2015;(1):70–78).
  3. Krieger J.N., Lee S.W., Jeon J. et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;Suppl 1:85–90. doi: 10.1016/j.ijantimicag.2007.08.028.
  4. Apolikhin O.I., Sivkov A.V., Komarova V.A., Nikushina A.A. Prostate diseases in the russian federation: statistical data for 2008-2017. Jeksperimental’naja i klinicheskaja urologija. 2019;(2):4–13. doi: 10.29188/2222-8543-2019-11-2-4-12. Russian (Аполихин О.И., Комарова В.А., Никушина А.А., Сивков А.В. Экспериментальная и клиническая урология. Болезни предстательной железы в Российской Федерации: статистические данные 2008–2017 гг. 2019;(2):4–13. doi: 10.29188/2222-8543-2019-11-2-4-12).
  5. Roberts R.O., Lieber M.M., Rhodes T., Girman C.J., Bostwick D.G., Jacobsen S.J. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology. 1998;51(4):578–584. doi: 10.1016/s0090-4295(98)00034-x.
  6. Zhang R., Sutcliffe S., Giovannucci E., Willett W.C., Platz E.A., Rosner B.A., Dimitrakoff J.D., Wu K. Lifestyle and Risk of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Cohort of United States Male Health Professionals. J Urol. 2015;194(5):1295–1300. doi: 10.1016/j.juro.2015.05.100.
  7. Gallo L. Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer Prostatic Dis. 2014;17(3):238–245. doi: 10.1038/pcan.2014.18.
  8. Vinnik Y.Y., Nikolaev V.G., Lebedev E.Y. Antrometric characteristics of patients with chronic urethrogenic prostatitis. Medicina i obrazovanie v Sibiri. 2013;(5):22. Russian (Винник Ю.Ю., Николаев В.Г., Лебедев Е.Ю. Антрометрическая характеристика больных хроническим уретрогенным простатитом. Медицина и образование в Сибири. 2013;(5):22).
  9. Fowke J.H., Koyama T., Fadare O. Clark P.E. Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms. PLoS One. 2016;11(6):e0156918. doi: 10.1371/journal.pone.0156918.
  10. Chen Y., Li J., Hu Y., et al. Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project. Sci Rep. 2017;7(1):9143. Published 2017 Aug 22. doi: 10.1038/s41598-017-09751-8.11. Perevoshchikova N.K., Seliverstov I.A., Drakina S.A., Chernykh N.S. Bioimpedance analysis in clinical practice. Mat’ i ditja v Kuzbasse. 2021;3(86):11–20. doi: 10.24412/2686-7338-2021-3-11-20. Russian (Перевощикова Н.К., Селиверстов И.А., Дракина С.А., Черных Н.С. Биоимпедансный анализ в клинической практике. Мать и дитя в Кузбассе. 2021;3(86):11–20. doi: 10.24412/2686-7338-2021-3-11-20).
  11. Mayne K.J., Shemilt R., Keane D.F., Lees J.S., Mark P.B., Herrington W.G. Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review. J Card Fail. 2022;28(11):1628–1641. doi: 10.1016/j.cardfail.2022.08.005.
  12. Mantzorou M., Tolia M., Poultsidi A., Pavlidou E., Papadopoulou S.K., Papandreou D., Giaginis C. Can Bioelectrical Impedance Analysis and BMI be a Prognostic Tool in Head and Neck Cancer Patients? A Review of the Evidence. Cancers (Basel). 2020;12(3):557. doi: 10.3390/cancers12030557.
  13. Thibault R., Makhlouf AM, Mulliez A, Cristina Gonzalez M, Kekstas G, Kozjek NR, Preiser J.C., Rozalen I.C., Dadet S., Krznaric Z., Kupczyk K., Tamion F., Cano N., Pichard C. Phase Angle Project Investigators. Fat-free mass at admission predicts 28-day mortality in intensive care unit patients: the international prospective observational study Phase Angle Project. Intensive Care Med. 2016;42(9):1445–1453. doi: 10.1007/s00134-016-4468-3.
  14. Loran O.B., Segal A.S. The system of summary assessment of symptoms in chronic prostatitis (SOS–CP). Urologiia. 2001;(5):16–19. Russian (Лоран О. Б., Сегал А.С. Система суммарной оценки симптомов при хроническом простатите (СОС–ХП). Урология. 2001;(5):16–19).
  15. Vasilchenko G.S., Botneva I.L. Vinnik Yu.Yu. et al. General sexopathology: a guide for doctors. M.: Medicine, 2005. 512 p. Russian (Васильченко Г.С., Ботнева И.Л. Винник Ю.Ю. и др. Общая сексопатология: руководство для врачей. М.: Медицина, 2005. 512 с.).
  16. Carter J.E.L., Heath B.H. Somatotyping: development and appli cations. Cambridge: Cambridge University Press, 1990.
  17. Nikolaev D.V., Rudnev S.G. Bioimpedance analysis: fundamentals of the method, examination protocol and interpretation of the results. Sports medicine: science and practice. 2012;(2):29–36. Russian (Николаев Д.В., Руднев С.Г. Биоимпедансный анализ: основы метода, протокол обследования и интерпретация результатов. Спортивная медицина: наука и практика. 2012;(2):29–36).
  18. Wang Y., He L., Zhou Z., Jin L., Meng J., Sun G., Na Y. The association between metabolic syndrome and the National Institutes of Health Chronic Prostatitis Symptom Index: results from 1673 men in China. Urology. 2013;82(5):1103–1107. doi: 10.1016/j.urology.2013.06.007.
  19. Trabert B., Graubard B.I., Nyante S.J., Rifai N., Bradwin G., Platz E.A., et al. Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer causes & control: CCC. 2012;23(12):1881–1891. doi: 10.1007/s10552-012-0024-9.
  20. Tyagi P., Motley S.S., Koyama T., Kashyap M., Gingrich J., Yoshimura N., Fowke J.H. Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients. Prostate. 2018;78(1):17–24. doi: 10.1002/pros.23439.
  21. Поздняк А.О., Фатхуллин А.Г. Особенности метаболизма андрогенов при распространенных заболеваниях у мужчин репродуктивного возраста. University Therapeutic Journal. 2021;3(1):49–57. Russian (Pozdnyak A.O., Fatkhullin A.G. Features of androgen metabolism in common diseases in men of reproductive age. University Therapeutic Journal. 2021;3(1):49–57).
  22. Mongraw-Chaffin M.L., Anderson C.A., Allison M.A., Ouyang P., Szklo M., Vaidya D., et al. Association between sex hormones and adiposity: qualitative differences in women and men in the multi-ethnic study of atherosclerosis. The Journal of clinical endocrinology and metabolism. 2015;100(4):E596–600. doi: 10.1210/jc.2014-2934.
  23. Korneyev I.A. Ejaculate parameters and the results of in vitro fertilization treatment in infertile couples with overweight and obese men. Urology reports (St.-Petersburg). 2022;12(1):41–48. doi: 10.17816/uroved99867. Russian (Корнеев И.А. Изучение показателей эякулята и результатов лечения с применением вспомогательных репродуктивных технологий мужчин с избыточным весом и ожирением, состоящих в бесплодном браке. Урологические ведомости. 2022;12(1):41–48. doi: 10.17816/uroved99867).
  24. Gacci M., Corona G., Sebastianelli A., Serni S., De Nunzio C., Maggi M., Vignozzi L., Novara G., McVary K.T., Kaplan S.A., Gravas S., Chapple C. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol. 2016;70(5):788–796. doi: 10.1016/j.eururo.2016.07.007.
  25. Hill M.A., Jaisser F., Sowers J.R. Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness. Cardiovasc Res. 2022;118(1):130–140. doi: 10.1093/cvr/cvaa326.
  26. Leopold J.A. Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension. 2013;62(6):1003. doi: 10.1161/HYPERTENSIONAHA.113.01872.
  27. De Leonardis F., Colalillo G., Finazzi Agrò E., Miano R., Fuschi A., Asimakopoulos A.D. Endothelial Dysfunction, Erectile Deficit and Cardiovascular Disease: An Overview of the Pathogenetic Links. Biomedicines. 2022;10(8):1848. doi: 10.3390/biomedicines 10081848
  28. Silveira Rossi J.L., Barbalho S.M, Reverete de Araujo R., Bechara M.D., Sloan K.P., Sloan L.A. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502. doi: 10.1002/dmrr.3502.
  29. Lima N., Cavaliere H., Knobel M., Halpern A., Medeiros-Neto G. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int. J. Obes. Relat. Metab. Disord. 2000;24:1433–1437. doi: 10.1038/sj.ijo.0801406.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. Localization of pain syndrome in CAPTB

Жүктеу (185KB)
Метадеректер
3. Fig. 2. Absolute (A) and relative (B) indices of component body composition in patients with WBCTB depending on somatotype HM - fat mass, BFM - fat-free mass, ACM - active-cell mass, OVnek.J - extracellular fluid volume, OVnuk.J - intracellular fluid volume.

Жүктеу (256KB)
Метадеректер
4. Fig. 3. Microscopy results of prostate secretion in patients with VSCTB depending on somatotype

Жүктеу (242KB)
Метадеректер

© Bionika Media, 2024

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>